Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

Low RiskFDA Drug
Medications & Supplements/Prescription Drugs

Amneal Pharmaceuticals, Inc.: Esterified Estrogen and Methyltestosterone Tablets Recalled for Low Potency

Agency Publication Date: July 1, 2019
Share:
Sign in to monitor this recall

Summary

Amneal Pharmaceuticals, Inc. is recalling 38,280 bottles of Esterified Estrogens & Methyltestosterone Tablets (0.625 mg/1.25 mg and 1.25 mg/2.5 mg strengths) because testing showed the medication may be subpotent. This means the tablets contain less of the active ingredient than they are supposed to, which could result in patients not receiving their full intended dose of medication. These prescription-only tablets were distributed nationwide in 100-count bottles. Patients should contact their healthcare provider or pharmacist regarding their medication use and return any remaining product to their pharmacy.

Risk

The drug is being recalled because it failed 'out of specification' assay results, meaning it is subpotent. If a patient takes subpotent medication, they may not receive the full therapeutic benefit of the hormones, potentially leading to a recurrence or worsening of the symptoms the medication was intended to treat.

What You Should Do

  1. Check your medication bottles for Esterified Estrogens & Methyltestosterone Tablets, USP 0.625 mg/1.25 mg (NDC 13925-171-01) with lot numbers HL05715 or HL05815 and an expiration date of 11/2017.
  2. Check your medication bottles for Esterified Estrogens & Methyltestosterone Tablets, USP 1.25 mg/2.5 mg (NDC 13925-172-01) with lot numbers HL06015 or HL06115 and an expiration date of 10/2017.
  3. Immediately contact your healthcare provider or pharmacist to discuss your treatment and determine if a replacement prescription is necessary.
  4. Return any remaining tablets from the affected lots to your pharmacy for a refund and to ensure the subpotent medication is properly handled.
  5. Contact Amneal Pharmaceuticals, Inc. at their Brookhaven, New York facility or through your distributing pharmacy for further instructions regarding this recall.
  6. For additional questions, contact the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) or visit www.fda.gov/safety/recalls.

Your Remedy Options

๐Ÿ’ฐFull Refund

Drug recall refund and consultation

How to: Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund

Affected Products

Product: Esterified Estrogens & Methyltestosterone Tablets, USP 0.625 mg/1.25 mg (100-count bottles)
Model:
NDC 13925-171-01
Recall #: D-1438-2019
Lot Numbers:
HL05715 (Exp. 11/2017)
HL05815 (Exp. 11/2017)
Date Ranges: Exp. 11/2017
Product: Esterified Estrogens & Methyltestosterone Tablets, USP 1.25 mg/2.5 mg (100-count bottles)
Model:
NDC 13925-172-01
Recall #: D-1439-2019
Lot Numbers:
HL06015 (Exp. 10/2017)
HL06115 (Exp. 10/2017)
Date Ranges: Exp. 10/2017

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 83137
Status: Resolved
Manufacturer: Amneal Pharmaceuticals, Inc.
Sold By: Seton Pharmaceuticals; Pharmacies nationwide
Manufactured In: United States
Units Affected: 2 products (19104 units; 19176 units)
Distributed To: Nationwide

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.